Budget 2018: New Medicines Listed on Pharmaceutical Benefits Scheme

Article published 26 May 2018

Subscribe to CPSA news


The Government will set aside $1.4 billion over five years for a number of new medicines on the Pharmaceutical Benefits Scheme (PBS) and the Repatriation Pharmaceutical Benefits Scheme (RPBS).

The new listings include medicines for illnesses including breast cancer, multiple sclerosis, refractory multiple myeloma, human immunodeficiency virus, relapsed or refractory Hodgkin lymphoma and spinal muscular atrophy.

The Government has also amended the prices of 34 medicines which are currently listed on the PBS and RPBS.

For more information call CPSA Head office on 1800 451 488.

For more information please email our media contact at media@cpsa.org.au

Stay up to date with CPSA news and media releases

Our regular email newsletter provides valuable insights and information on topics such as pension entitlements, healthcare, government policies, and more.

  • This field is for validation purposes and should be left unchanged.